|
ESPL1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.836300E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.644400E-02 |
| Normal-vs-Stage2 |
8.780200E-03 |
| Normal-vs-Stage3 |
1.654370E-01 |
| Normal-vs-Stage4 |
5.796800E-01 |
| Stage1-vs-Stage2 |
3.176200E-01 |
| Stage1-vs-Stage3 |
1.252040E-01 |
| Stage1-vs-Stage4 |
2.958700E-03 |
| Stage2-vs-Stage3 |
3.765600E-02 |
| Stage2-vs-Stage4 |
1.495630E-03 |
| Stage3-vs-Stage4 |
1.879560E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.488400E-02 |
| Normal-vs-AfricanAmerican |
2.587800E-02 |
| Normal-vs-Asian |
6.668000E-01 |
| Caucasian-vs-AfricanAmerican |
2.761200E-01 |
| Caucasian-vs-Asian |
3.390000E-01 |
| AfricanAmerican-vs-Asian |
2.578600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.470000E-02 |
| Normal-vs-Female |
6.000400E-02 |
| Male-vs-Female |
8.522600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.231600E-01 |
| Normal-vs-Age(41-60Yrs) |
6.340400E-02 |
| Normal-vs-Age(61-80Yrs) |
7.013700E-02 |
| Normal-vs-Age(81-100Yrs) |
4.842400E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.694600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.069800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.777600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.408600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.211400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.485400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.838210E-01 |
| Normal-vs-Grade 2 |
1.433970E-02 |
| Normal-vs-Grade 3 |
1.250040E-01 |
| Normal-vs-Grade 4 |
5.584800E-01 |
| Grade 1-vs-Grade 2 |
5.946600E-01 |
| Grade 1-vs-Grade 3 |
7.933800E-01 |
| Grade 1-vs-Grade 4 |
4.284600E-01 |
| Grade 2-vs-Grade 3 |
2.655500E-02 |
| Grade 2-vs-Grade 4 |
9.281000E-03 |
| Grade 3-vs-Grade 4 |
1.721840E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.021900E-02 |
| Normal-vs-ccB subtype |
5.385600E-02 |
| ccA subtype-vs-ccB subtype |
8.960800E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.413800E-02 |
| Normal-vs-N1 |
4.045000E-01 |
| N0-vs-N1 |
2.469600E-02 |
|
|
